Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort
Open Access
- 1 March 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (3) , 655-660
- https://doi.org/10.1158/1055-9965.epi-07-2683
Abstract
Background: Studies of postmenopausal hormone therapy and lung cancer incidence have reported positive, negative, and null associations. Most of these studies, however, have had limited ability to control rigorously for cigarette smoking or to examine risk separately by smoking status.Keywords
This publication has 23 references indexed in Scilit:
- Estrogen receptor signaling pathways in human non-small cell lung cancerSteroids, 2007
- Progesterone Receptor in Non–Small Cell Lung Cancer—A Potent Prognostic Factor and Possible Target for Endocrine TherapyCancer Research, 2005
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Estrogen replacement therapy and risk of lung cancerPharmacoepidemiology and Drug Safety, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Do women live longer following lung resection for carcinoma?European Journal of Cardio-Thoracic Surgery, 2002
- The American Cancer Society Cancer Prevention Study II Nutrition CohortCancer, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Re: Endocrine Factors and Adenocarcinoma of the Lung in WomenJNCI Journal of the National Cancer Institute, 1994
- Steroid receptors in human lung cancer cytosolsCancer Letters, 1982